HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M500006-MCP200v1 M500006-MCP200v2 M500006-MCP200v3 M500006-MCP200v4 4/4/409    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Veenstra, T. D. Articles by Morrison, R. S. Search for Related Content PubMed PubMed Citation Articles by Veenstra, T. D. Articles by Morrison, R. S. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:409-418, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Biomarkers: Mining the Biofluid Proteome^*

Timothy D. Veenstra^,, Thomas P. Conrads, Brian L. Hood, Anthony M. Avellino^¶, Richard G. Ellenbogen^¶ and Richard S. Morrison^¶

From the Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702-1201
^¶ Department of Neurological Surgery, University of Washington School of Medicine, Seattle, WA 98195

Proteomics has brought with it the hope of identifying novel biomarkers for diseases such as cancer. This hope is built on the ability of proteomic technologies, such as mass spectrometry (MS), to identify hundreds of proteins in complex biofluids such as plasma and serum. There are many factors that make this research very challenging beginning with the lack of standardization of sample collection and continuing through the entire analytical process. Fortunately the advances made in the characterization of biofluids using proteomic techniques have been rapid and suggest that these mainly discovery driven approaches will lead to the development of highly specific platforms for diagnosing diseases and monitoring responses to different treatments in the near future.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. A. Collins, S. P. Mirza, A. H. Kissebah, and M. Olivier Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry Physiol Genomics, February 1, 2010; 40(3): 208 - 215. [Abstract] [Full Text] [PDF]

				C.-S. Chen, S. Sullivan, T. Anderson, A. C. Tan, P. J. Alex, S. R. Brant, C. Cuffari, T. M. Bayless, M. V. Talor, C. L. Burek, et al. Identification of Novel Serological Biomarkers for Inflammatory Bowel Disease Using Escherichia coli Proteome Chip Mol. Cell. Proteomics, August 1, 2009; 8(8): 1765 - 1776. [Abstract] [Full Text] [PDF]

				N. S. Nagaraj Evolving 'omics' technologies for diagnostics of head and neck cancer Briefings in Functional Genomics, March 9, 2009; (2009) elp004v1. [Abstract] [Full Text] [PDF]

				A. V. G. Edwards, M. Y. White, and S. J. Cordwell The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837. [Abstract] [Full Text] [PDF]

				D. Martins de Souza, B. M. Oliveira, E. Castro-Dias, F. V. Winck, R. S. O. Horiuchi, P. A. Baldasso, H. T. Caetano, N. K. D. Pires, S. Marangoni, and J. C. Novello The untiring search for the most complete proteome representation: reviewing the methods Briefings in Functional Genomics, July 1, 2008; 7(4): 312 - 321. [Abstract] [Full Text] [PDF]

				N. Seam, D. A. Gonzales, S. J. Kern, G. L. Hortin, G. T. Hoehn, and A. F. Suffredini Quality Control of Serum Albumin Depletion for Proteomic Analysis Clin. Chem., November 1, 2007; 53(11): 1915 - 1920. [Abstract] [Full Text] [PDF]

				Y. Kita, Y. Miura, J.-i. Furukawa, M. Nakano, Y. Shinohara, M. Ohno, A. Takimoto, and S.-I. Nishimura Quantitative Glycomics of Human Whole Serum Glycoproteins Based on the Standardized Protocol for Liberating N-Glycans Mol. Cell. Proteomics, August 1, 2007; 6(8): 1437 - 1445. [Abstract] [Full Text] [PDF]

				N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn Proteomics in Clinical Trials and Practice: Present Uses and Future Promise Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829. [Abstract] [Full Text] [PDF]

				W.-J. Qian, J. M. Jacobs, T. Liu, D. G. Camp II, and R. D. Smith Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications Mol. Cell. Proteomics, October 1, 2006; 5(10): 1727 - 1744. [Abstract] [Full Text] [PDF]